|
RPRX
|
Royalty Pharma plc
|
0.26%
|
US
|
NASDAQ
|
|
TECH
|
Techne Corporation
|
0.25%
|
US
|
NASDAQ
|
|
TFX
|
Teleflex Incorporated
|
0.23%
|
US
|
NYSE
|
|
CRL
|
Charles River Laboratories International, Inc.
|
0.22%
|
US
|
NYSE
|
|
HSIC
|
Henry Schein, Inc.
|
0.21%
|
US
|
NASDAQ
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
0.20%
|
US
|
NASDAQ
|
|
EXAS
|
Exact Sciences Corporation
|
0.20%
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
0.18%
|
US
|
NASDAQ
|
|
UHS
|
Universal Health Services, Inc.
|
0.18%
|
US
|
NYSE
|
|
BIO
|
Bio-Rad Laboratories, Inc.
|
0.18%
|
US
|
NYSE
|
|
RGEN
|
Repligen Corporation
|
0.16%
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
0.16%
|
US
|
NASDAQ
|
|
CTLT
|
Catalent, Inc.
|
0.16%
|
US
|
NYSE
|
|
MASI
|
Masimo Corporation
|
0.15%
|
US
|
NASDAQ
|
|
XRAY
|
DENTSPLY International Inc.
|
0.14%
|
US
|
NASDAQ
|
|
ELAN
|
Elanco Animal Health Incorporated
|
0.10%
|
US
|
NYSE
|
|
DVA
|
DaVita HealthCare Partners Inc.
|
0.08%
|
US
|
NYSE
|